Nutriband inc. reports second quarter 2023 financial results and provides business update

Second quarter 2023 revenues increased 48% compared to second quarter 2022 orlando, fl / accesswire / september 11, 2023 / nutriband inc. (nasdaq:ntrb)(nasdaq:ntrbw), a developer of transdermal pharmaceutical products, today announced financial and operational results for the second quarter ended july 31, 2023. key highlights: generated quarterly revenue of $655,928, up 48% over q2 2022 revenue for six-months ended july 31, 2023, was $1,132,869, up 21% year-over-year increased existing credit line to $5 million supporting the continued development of aversa launched ai tape brand and announced donovan mcnabb as ai tape brand ambassador stockholders' equity of $6.9 million as of july 31, 2023 "we are encouraged by the continued revenue growth from nutriband's subsidiaries, especially our pocono pharmaceuticals segment.
NTRB Ratings Summary
NTRB Quant Ranking